How many insider declarations has 吴希振 filed?

吴希振 has filed 6 public insider declarations with SSE / SZSE (CSRC).

What is 吴希振's role?

吴希振 reports trades in the capacity of 董事.

Which companies does 吴希振 report trades for?

吴希振 reports trades for 羚锐制药.

吴

吴希振

董事

Board

·SSE / SZSE (CSRC)

羚锐制药

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Browse the full record of transactions filed by 吴希振, 董事. Director active across 1 company, notably 羚锐制药. In total, 6 reports have been published. Regulator: SSE / SZSE (CSRC). All data is openly available.

Companies and markets linked to 吴希振

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

羚锐制药 (CN)

申报6 总计

●

李进

董事高管2024年6月26日千禾味业

7SSE ↗

110,000 股A股XSHGSSE:173000007791354000

●

李进

监事高管2024年5月24日羚锐制药

7SSE ↗

47,600 股A股XSHGSSE:173000007691012130

●

吴希振

董事高管2023年2月22日羚锐制药

7SSE ↗

80,000 股A股XSHGSSE:173000006302345950

●

吴希振

董事高管2022年5月6日羚锐制药

7SSE ↗

5,000 股A股XSHGSSE:173000005506994780

●

熊维政

董事长,总裁高管2021年11月5日羚锐制药

22SSE ↗

527,300 股A股XSHGSSE:173000005041325920

●

熊维政

董事长,总裁高管2021年11月3日羚锐制药

22SSE ↗

1,248,800 股A股XSHGSSE:173000005075801470

6 条申报中的 6 条

About 吴希振

Wu Xizhen is a board member of Lingrui Pharmaceutical. He participates in governance and strategic decision-making for the company.

InsidersTradesSigma

← Executives ★ Sign in to follow

吴

吴希振

董事

Board

·SSE / SZSE (CSRC)

羚锐制药

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Browse the full record of transactions filed by 吴希振, 董事. Director active across 1 company, notably 羚锐制药. In total, 6 reports have been published. Regulator: SSE / SZSE (CSRC). All data is openly available.